Results 101 to 110 of about 19,293 (297)

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

BMC Cancer, 2019
Upfront cytoreductive surgery with HIPEC (CRS-HIPEC) is the standard treatment for isolated resectable colorectal peritoneal metastases (PM) in the Netherlands.
K. Rovers, C. Bakkers, G. Simkens, J. Burger, S. Nienhuijs, G. Creemers, A. M. Thijs, A. Brandt-Kerkhof, E. Madsen, N. Ayez, N. L. de Boer, E. van Meerten, J. Tuynman, M. Kusters, N. Sluiter, H. Verheul, H. J. van der Vliet, M. Wiezer, D. Boerma, E. Wassenaar, M. Los, C. B. Hunting, A. Aalbers, N. Kok, K. Kuhlmann, H. Boot, M. Chalabi, S. Kruijff, L. Been, R. V. van Ginkel, D. D. de Groot, R. Fehrmann, J. D. de Wilt, A. Bremers, P. D. de Reuver, S. Radema, K. Herbschleb, W. V. van Grevenstein, A. Witkamp, M. Koopman, N. Haj Mohammad, E. V. van Duyn, W. Mastboom, L. Mekenkamp, J. Nederend, M. Lahaye, P. Snaebjornsson, C. Verhoef, H. V. van Laarhoven, A. Zwinderman, J. Bouma, O. Kranenburg, I. van ’t Erve, R. Fijneman, M. Dijkgraaf, P. Hemmer, C. Punt, P. Tanis, I. D. de Hingh   +58 more
semanticscholar   +1 more source

Worldwide barriers of optimal surgical care provision in advanced ovarian cancer

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 129-137, September 2025.
Abstract Ovarian cancer (OC) remains one of the most challenging gynecological malignancies to cure, despite recent advances in treatment. Disparities in the diagnosis, management, and survival of OC exist worldwide and addressing them remains an ongoing challenge.
Shriya Varghese, Myong Cheol Lim, Robert Armbrust, Rene Pareja, Christina Fotopoulou   +4 more
wiley   +1 more source

Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy

International Journal of Hyperthermia
Purpose Cisplatin is commonly prescribed in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Acute kidney injury (AKI) is regarded as a common complication after HIPEC combined with cytoreductive surgery (CRS).
Chih-Chung Cheng, Hung-Chieh Yeh, Pei-Wen Su, Chien-Lin Ho, Sheng-Chi Chang   +4 more
doaj   +1 more source

Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]

, 2016
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P., Castro Mesta, Julio Fernando, González Guerrero, Juan Francisco, Villarreal Cavazos, Gerardo   +3 more
core  

Targeting the tumor microenvironment in colorectal peritoneal metastases

, 2020
Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC) patients. The pathophysiology of colorectal PM remains poorly characterized. Also, the efficacy of current treatment modalities, including surgery and intraperitoneal (
Ceelen, Wim, De Wever, Olivier, Heriot, Alexander G., Narasimhan, Vignesh, Ramsay, Robert G.   +4 more
core   +1 more source

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015 [PDF]

, 2015
Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases.
Alonso, V., Aparicio, Jesús F., Aranda, E., García Albeniz, X., García Alfonso, P., García Carbonero, Rocío, Salazar, Ramón, Valladares, M., Vera, R., Viéitez de Prado, José María   +9 more
core   +3 more sources

HIPEC: The Complexities of Clinical Trials [PDF]

Annals of Surgical Oncology, 2008
The treatment of peritoneal surface malignancies presents unique and challenging problems to the cancer clinician. These patients more than many other cancer patients often suffer from significant and disabling symptoms as a direct result of local tumor progression.
openaire   +2 more sources

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 6-35, September 2025.
Abstract In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs).
Malte Renz, Michael Friedlander, Jonathan S. Berek   +2 more
wiley   +1 more source

Treatments and overall survival in patients with Krukenberg tumor [PDF]

, 2019
BACKGROUND: Krukenberg tumor (KT) is a rare secondary ovarian tumor, primarily localized at the gastrointestinal tract in most cases. KT is related to severe prognosis due to its aggressiveness, diagnostic difficulties and poor treatment efficacy ...
Corcione, Francesco, D'Armiento, Maria, De Luca, Marcello, Insabato, Luigi, Lionetti, Ruggero, Mascolo, Massimo, Raffone, Antonio, Saccone, Gabriele, Travaglino, Antonio, Zullo, Fulvio   +9 more
core   +1 more source

LB002/#1545 Late-breaking abstract presentation: comparative effectiveness of HIPEC following interval cytoreductive surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy: multicenter, prospective, cohort study (KGOG 3042) [PDF]

, 2022
Yong Jae Lee, Joo‐Hyuk Son, Min Chul Choi, Dong Hoon Suh, Dae Gy Hong, Mi‐Kyung Kim, Jae‐Hoon Kim, Jung‐Yun Lee, Suk‐Joon Chang   +8 more
openalex   +1 more source